Agreed—with one minor alteration: the 4-week results from the IDX184 phase-2a trial do not constitute RVR data for the reason mentioned in the * footnote of #msg-47150426. Regards, Dew
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”